| 前收盘价格 | 182.08 |
| 收盘价格 | 182.12 |
| 成交量 | 30,778 |
| 平均成交量 (3个月) | 754,198 |
| 市值 | 11,591,822,336 |
| 市盈率 (P/E TTM) | 15.35 |
| 预期市盈率 (P/E Forward) | 9.95 |
| 价格/销量 (P/S) | 0.910 |
| 股市价格/股市净资产 (P/B) | 21.63 |
| 52周波幅 | |
| 利润日期 | 28 Oct 2026 |
| 营业毛利率 | 6.63% |
| 营业利益率 (TTM) | 13.44% |
| 稀释每股收益 (EPS TTM) | 10.08 |
| 季度收入增长率 (YOY) | 5.00% |
| 季度盈利增长率 (YOY) | -32.00% |
| 总债务/股东权益 (D/E MRQ) | 742.20% |
| 流动比率 (MRQ) | 1.25 |
| 营业现金流 (OCF TTM) | 2.34 B |
| 杠杆自由现金流 (LFCF TTM) | 1.58 B |
| 资产报酬率 (ROA TTM) | 7.04% |
| 股东权益报酬率 (ROE TTM) | 54.79% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Care Facilities (US) | 混合的 | 混合的 |
| Medical Care Facilities (全球的) | 看涨 | 看涨 | |
| 股票 | DaVita Inc. | 混合的 | 看涨 |
AIStockmoo 评分
1.8
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 3.5 |
| 技术振荡指标 | 3.0 |
| 相对估值 | -5.0 |
| 财务健康 | 2.5 |
| AI Insight | NA |
| 平均 | 1.81 |
|
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. |
|
| 部门 | Healthcare |
| 行业 | Medical Care Facilities |
| 投资方式 | Small Core |
| 内部持股比例 | 49.51% |
| 机构持股比例 | 48.76% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Berkshire Hathaway Inc | 30 Jun 2026 | 28,880,209 |
| Neuberger Berman Group Llc | 30 Jun 2026 | 925,579 |
| Gates Capital Management, Inc. | 30 Jun 2026 | 688,136 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合